Cost of humira injections?

See the DrugPatentWatch profile for humira

What do Humira injections cost for patients?

The cost of Humira injections can be quite high for patients. According to DrugPatentWatch.com, the average wholesale price (AWP) for a single prefilled syringe of Humira (adalimumab) is around $2,850-$3,500. This price does not include additional costs such as insurance copays, patient assistance programs, and potential discounts.

How much do Humira injections cost without insurance?

Without insurance, the cost of a single Humira injection can range from $4,500 to over $6,000, depending on the location and pharmacy.

What assistance programs are available for Humira patients?

AbbVie, the manufacturer of Humira, offers several patient assistance programs to help make the medication more affordable. The AbbVie Patient Foundation provides free or low-cost medication to eligible patients. Additionally, patients may be able to access Humira through patient assistance programs offered by advocacy groups, such as the Humira Patient Support Program.

Can Humira patients take advantage of generic or biosimilar alternatives?

In 2023, the U.S. FDA approved AbbVie's adalimumab biosimilars, such as Amjevita (adalimumab-aacf) and Cyltezo (adalimumab-adbm), which are expected to offer more affordable options for patients. However, prices for these biosimilars are still uncertain, and their availability may be limited in the short term.

When do patents for Humira expire?

The U.S. patent for Humira expires in 2023, which may lead to increased competition from generic or biosimilar alternatives. However, even after patent expiration, AbbVie still holds exclusivity agreements that restrict generic versions from entering the market.

Sources:

1. DrugPatentWatch.com
2. AbbVie Patient Foundation
3. National Psoriasis Foundation